• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VANTIVE US HEALTHCARE LLC PRISMAFLEX ST SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VANTIVE US HEALTHCARE LLC PRISMAFLEX ST SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 107640US
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemolysis (1886); Hematuria (2558)
Date of Event 02/19/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient was receiving continuous renal replacement therapy (crrt) treatment using prismaflex st150 set.It was reported that, during therapy, hematuria and blood in the effluent were observed.The patient underwent unspecified blood investigations and was reported to experience hemolysis.Treatment was stopped.No additional information is available.
 
Additional Manufacturer Narrative
Prismaflex st150 set has been temporarily approved for use in the us under emergency use authorization eua (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
H11: the actual device was not available; however, photographs of the sample were provided for evaluation.Visual inspection of the photos showed that the set effluent circuit had a blood-tinged coloration.The reported condition was verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The cause of the condition was not determined as no further or actual sample testing could be conducted.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX ST SET
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
VANTIVE US HEALTHCARE LLC
deerfield IL
Manufacturer (Section G)
VANTIVE HEALTHCARE - MEYZIEU
7, av. lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
510 lake cook rd
deerfield, il, IL 60015
8153072966
MDR Report Key24606033
Report Number8010182-2026-00219
Device Sequence Number10402572
Product Code KDI
UDI-Device Identifier00085412917696
UDI-Public0085412917696
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K212216
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Remedial Action Notification
Type of Report Initial,Followup
Report Date (Section B) 04/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number107640US
Device Lot Number25G0028CD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/20/2026
Supplement Date Received by Manufacturer04/13/2026
Initial Report FDA Received Date03/16/2026
Supplement Report FDA Received Date04/17/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/01/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
8010182-12/17/25-001-C
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-